ID

38780

Descrição

Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01734785

Link

https://clinicaltrials.gov/show/NCT01734785

Palavras-chave

Versões (1)
  1. 03/11/2019 03/11/2019 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

3 de novembro de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Diabetes Mellitus, Type 2 NCT01734785

Inglês

Eligibility Diabetes Mellitus, Type 2 NCT01734785

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. diagnosis of type 2 diabetes mellitus.
Descrição

Diabetes Mellitus, Non-Insulin-Dependent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0011860
2. male and female patients on diet and exercise regimen, pre-treated with immediate release metformin for at least 12 weeks, and patients should be on a dose higher or equal to 1500 mg/day of metformin, or maximum tolerated dose, or maximum dose as per local label.
Descrição

Gender | Diet therapy | Exercise | Pretreatment Metformin Immediate Release | Metformin Dose U/day | Metformin Maximum Tolerated Dose

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0012159
UMLS CUI [3]
C0015259
UMLS CUI [4,1]
C3539076
UMLS CUI [4,2]
C0025598
UMLS CUI [4,3]
C1708470
UMLS CUI [5,1]
C0025598
UMLS CUI [5,2]
C0178602
UMLS CUI [5,3]
C0456683
UMLS CUI [6,1]
C0025598
UMLS CUI [6,2]
C0752079
3. hba1c higher or equal to 8.0% and lower or equal to 10.5% at screening visit.
Descrição

Hemoglobin A1c measurement

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0474680
4. age 18 years or more at screening.
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
5. body mass index lower or equal to 45 kg/m2 at screening visit.
Descrição

Body mass index

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1305855
6. signed and dated written informed consent.
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. uncontrolled hyperglycemia with glucose level above 270 mg/dl (above 15 mmol/dl) after an overnight fast.
Descrição

Hyperglycemia Uncontrolled | Glucose level | Status post Fasting Overnight

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0020456
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0428548
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C0015663
UMLS CUI [3,3]
C0439583
2. use of any other antidiabetic drug (except metformin background therapy).
Descrição

Antidiabetics | Exception Metformin Background Therapy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0935929
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0025598
UMLS CUI [2,3]
C1706907
UMLS CUI [2,4]
C0087111
3. acute coronary syndrome, stroke or tia within 3 months prior to informed consent.
Descrição

Acute Coronary Syndrome | Cerebrovascular accident | Transient Ischemic Attack

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0948089
UMLS CUI [2]
C0038454
UMLS CUI [3]
C0007787
4. indication of liver disease.
Descrição

Indication Liver disease

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0023895
5. impaired renal function.
Descrição

Renal Insufficiency

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1565489
6. gastrointestinal surgery.
Descrição

Gastrointestinal Surgical Procedure

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0524722
7. treatment with anti-obesity drugs within 3 months prior to screening, or any other treatment at the time of screening (i.e. surgery, aggressive diet regimen, etc.) leading to unstable body weight.
Descrição

Anti-Obesity Agents | Treatment Resulting in Body Weight Unstable | Operative Surgical Procedures | Diet therapy Aggressive

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0376607
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0332294
UMLS CUI [2,3]
C0005910
UMLS CUI [2,4]
C0443343
UMLS CUI [3]
C0543467
UMLS CUI [4,1]
C0012159
UMLS CUI [4,2]
C0580822
8. current treatment with systemic steroids at time of informed consent or uncontrolled endocrine disorder except type 2 diabetes mellitus.
Descrição

Systemic steroids | Endocrine System Disease Uncontrolled | Exception Non-Insulin-Dependent Diabetes Mellitus

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2825233
UMLS CUI [2,1]
C0014130
UMLS CUI [2,2]
C0205318
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0011860
Voltar ao início da página

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT01734785

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
1. diagnosis of type 2 diabetes mellitus.
boolean
C0011860 (UMLS CUI [1])
Gender | Diet therapy | Exercise | Pretreatment Metformin Immediate Release | Metformin Dose U/day | Metformin Maximum Tolerated Dose
Item
2. male and female patients on diet and exercise regimen, pre-treated with immediate release metformin for at least 12 weeks, and patients should be on a dose higher or equal to 1500 mg/day of metformin, or maximum tolerated dose, or maximum dose as per local label.
boolean
C0079399 (UMLS CUI [1])
C0012159 (UMLS CUI [2])
C0015259 (UMLS CUI [3])
C3539076 (UMLS CUI [4,1])
C0025598 (UMLS CUI [4,2])
C1708470 (UMLS CUI [4,3])
C0025598 (UMLS CUI [5,1])
C0178602 (UMLS CUI [5,2])
C0456683 (UMLS CUI [5,3])
C0025598 (UMLS CUI [6,1])
C0752079 (UMLS CUI [6,2])
Hemoglobin A1c measurement
Item
3. hba1c higher or equal to 8.0% and lower or equal to 10.5% at screening visit.
boolean
C0474680 (UMLS CUI [1])
Age
Item
4. age 18 years or more at screening.
boolean
C0001779 (UMLS CUI [1])
Body mass index
Item
5. body mass index lower or equal to 45 kg/m2 at screening visit.
boolean
C1305855 (UMLS CUI [1])
Informed Consent
Item
6. signed and dated written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hyperglycemia Uncontrolled | Glucose level | Status post Fasting Overnight
Item
1. uncontrolled hyperglycemia with glucose level above 270 mg/dl (above 15 mmol/dl) after an overnight fast.
boolean
C0020456 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0428548 (UMLS CUI [2])
C0231290 (UMLS CUI [3,1])
C0015663 (UMLS CUI [3,2])
C0439583 (UMLS CUI [3,3])
Antidiabetics | Exception Metformin Background Therapy
Item
2. use of any other antidiabetic drug (except metformin background therapy).
boolean
C0935929 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
C1706907 (UMLS CUI [2,3])
C0087111 (UMLS CUI [2,4])
Acute Coronary Syndrome | Cerebrovascular accident | Transient Ischemic Attack
Item
3. acute coronary syndrome, stroke or tia within 3 months prior to informed consent.
boolean
C0948089 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0007787 (UMLS CUI [3])
Indication Liver disease
Item
4. indication of liver disease.
boolean
C3146298 (UMLS CUI [1,1])
C0023895 (UMLS CUI [1,2])
Renal Insufficiency
Item
5. impaired renal function.
boolean
C1565489 (UMLS CUI [1])
Gastrointestinal Surgical Procedure
Item
6. gastrointestinal surgery.
boolean
C0524722 (UMLS CUI [1])
Anti-Obesity Agents | Treatment Resulting in Body Weight Unstable | Operative Surgical Procedures | Diet therapy Aggressive
Item
7. treatment with anti-obesity drugs within 3 months prior to screening, or any other treatment at the time of screening (i.e. surgery, aggressive diet regimen, etc.) leading to unstable body weight.
boolean
C0376607 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0332294 (UMLS CUI [2,2])
C0005910 (UMLS CUI [2,3])
C0443343 (UMLS CUI [2,4])
C0543467 (UMLS CUI [3])
C0012159 (UMLS CUI [4,1])
C0580822 (UMLS CUI [4,2])
Systemic steroids | Endocrine System Disease Uncontrolled | Exception Non-Insulin-Dependent Diabetes Mellitus
Item
8. current treatment with systemic steroids at time of informed consent or uncontrolled endocrine disorder except type 2 diabetes mellitus.
boolean
C2825233 (UMLS CUI [1])
C0014130 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0011860 (UMLS CUI [3,2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial